Literature DB >> 3757916

Hypercalcemia in glucocorticoid withdrawal.

K Suzuki, K Nonaka, K Ichihara, Y Fukumoto, A Miyazaki, Y Yamada, Y Itoh, Y Seino, K Moriwaki, S Tarui.   

Abstract

We found severe hypercalcemia in the course of hydrocortisone withdrawal in a patient who had undergone unilateral adrenalectomy to resect a cortisol-hypersecreting adenoma. Serum calcium gradually but progressively increased after unilateral adrenalectomy. Severe hypercalcemia developed on the 77th postoperative day (the 15th day after discontinuing hydrocortisone replacement). The serum concentration of calcium, PTH, 25(OH)D, and 1,25(OH)2D were 8.0 mEq/l, less than 100 pg/ml, 10.1 ng/ml and 29.6 pg/ml, respectively. This hypercalcemia was accompanied by marked urinary hydroxyproline excretion and less calcium excretion in the urine than the prevailing level of serum calcium. Serum concentrations of 25(OH)D, 1,25(OH)2D and PTH were not elevated during the severe hypercalcemia. We concluded that the hypercalcemia in this patient was due in part to enhanced bone resorption and increased renal tubular reabsorption of calcium as a result of glucocorticoid withdrawal, but not to the elevation of serum PTH or serum 25(OH)D and serum 1,25(OH)2D.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3757916     DOI: 10.1507/endocrj1954.33.203

Source DB:  PubMed          Journal:  Endocrinol Jpn        ISSN: 0013-7219


  5 in total

1.  Transcatheter arterial chemo-embolization for humoral hypercalcemia of hepatocellular carcinoma.

Authors:  K Suzuki; N Kono; A Ono; Y Osuga; H Kiyokawa; I Mineo; Y Matsuda; S Miyoshi; S Kawata; Y Minami
Journal:  Gastroenterol Jpn       Date:  1988-02

2.  Hypercalcemia in a patient with autoimmune polyglandular syndrome.

Authors:  Svetlana Katsnelson; Jessica Cella; Heesuk Suh; Marina M Charitou
Journal:  Clin Pract       Date:  2012-04-04

3.  Hypercalcemia after the Discontinuation of Medroxyprogesterone Acetate.

Authors:  Erina Yuasa-Shibasaki; Sumiyasu Ishii; Shunichi Matsumoto; Takuya Tomaru; Kazuhiko Horiguchi; Aya Osaki; Atsushi Ozawa; Nobuyuki Shibusawa; Tetsurou Satoh; Masanobu Yamada
Journal:  Intern Med       Date:  2017-12-08       Impact factor: 1.271

4.  Infants With Congenital Adrenal Hyperplasia Are at Risk for Hypercalcemia, Hypercalciuria, and Nephrocalcinosis.

Authors:  Melissa J Schoelwer; Vidhya Viswanathan; Amy Wilson; Corina Nailescu; Erik A Imel
Journal:  J Endocr Soc       Date:  2017-08-01

Review 5.  Glucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome.

Authors:  Xin He; James W Findling; Richard J Auchus
Journal:  Pituitary       Date:  2022-04-26       Impact factor: 3.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.